Clinical trial shows common drug heparin can be used to improve COVID-19 symptoms
20th Jan 2022
Researchers have determined that a cheap and widely available blood-thinning drug can be used to treat COVID-19 patients by improving their breathing.
Professor Van Haren, who is also ICU Director at Sydney’s St George hospital, said the study’s findings were “promising” and could mean fewer people with COVID-19 end up in the intensive care unit (ICU).
Professor Van Heparin? – Mick Raven